PCE

LOE Approaching

erythromycin

NDAORALTABLET, COATED PARTICLES
Approved
Sep 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
13

Clinical Trials (5)

NCT06948747Phase 1Completed

A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Started May 2025
49 enrolled
Healthy Participants
NCT06917872Phase 1Completed

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Started Apr 2025
20 enrolled
Healthy
NCT05966493Phase 2Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Started Aug 2023
84 enrolled
Persistent Corneal Epithelial Defect
NCT05797753Phase 1Completed

A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

Started Feb 2022
16 enrolled
Amyotrophic Lateral SclerosisHealthy Volunteer
NCT03480243Phase 1Completed

Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil

Started Mar 2018
28 enrolled
Pharmacokinetics